Glycine

甘氨酸

Report date: 2023/07/26 15:17:42

Base Information

Drug NameGlycine
Drug Alias Nameglycinum氨基乙酸glycine氨基醋酸glicina +[7] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionAmino acid replacements
TargetsNot applicable
Therapy Area/IndicationsDietary SupplementCoronavirus Disease 2019 (COVID-19)Schizophrenia +[9] 
Global Approved IndicationsUrinary Bladder Diseases
Approved Indications in ChinaUrinary Bladder Diseases
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryUnited StatesMexicoMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesIndiana UniversityShanghai Huayuan Changfu Pharmaceutical Group Jingde Pharmaceutical Co Ltd
Inactive CompaniesYale UniversityInstituto Nacional De Enfermedades RespiratoriasNational Institute Of Mental Health (Nimh)
Active IndicationsDietary SupplementCoronavirus Disease 2019 (COVID-19)Urinary Bladder Diseases
Inactive IndicationsSchizophreniaPsychotic DisordersBipolar Disorder +[6] 

Other Information

ATC CodeB02AAB05BA01B05CX03 +[4] 
Related LinksWikipediaDrugBankKEGG